Please use this identifier to cite or link to this item:
|Title:||Fluvastatin: Efficacy and safety in reducing cardiac events||Authors:||Chan, M.Y.
|Issue Date:||Sep-2005||Citation:||Chan, M.Y., Lee, C.H. (2005-09). Fluvastatin: Efficacy and safety in reducing cardiac events. Expert Opinion on Pharmacotherapy 6 (11) : 1883-1895. ScholarBank@NUS Repository. https://doi.org/10.1517/146565220.127.116.113||Abstract:||The importance of statin therapy in lipid-lowering and its role in primary and secondary prevention has been borne out of numerous clinical trials conducted over the last two decades. Concurrently, much concern has been expressed over the safety and tolerability of these drugs. Fluvastatin has demonstrated good clinical efficacy and safety. This paper reviews the various pharmacological properties and evidence supporting its use in the prevention of cardiac events. © 2005 Ashley Publications Ltd.||Source Title:||Expert Opinion on Pharmacotherapy||URI:||http://scholarbank.nus.edu.sg/handle/10635/133067||ISSN:||14656566||DOI:||10.1517/14656518.104.22.1683|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Apr 4, 2020
WEB OF SCIENCETM
checked on Mar 19, 2020
checked on Mar 27, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.